NO921852L - N-substituerte azaheterosykliske karboksylsyrer og en farmasoeytisk sammensetning - Google Patents

N-substituerte azaheterosykliske karboksylsyrer og en farmasoeytisk sammensetning

Info

Publication number
NO921852L
NO921852L NO92921852A NO921852A NO921852L NO 921852 L NO921852 L NO 921852L NO 92921852 A NO92921852 A NO 92921852A NO 921852 A NO921852 A NO 921852A NO 921852 L NO921852 L NO 921852L
Authority
NO
Norway
Prior art keywords
carboxylic acids
image
substituted
pharmaceutical composition
alkyl
Prior art date
Application number
NO92921852A
Other languages
English (en)
Other versions
NO921852D0 (no
NO177853B (no
NO177853C (no
Inventor
Knud Erik Andersen
Lars Jacob Stray Knudsen
Ursula Sonnewald
Per Olaf Soerensen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO921852D0 publication Critical patent/NO921852D0/no
Publication of NO921852L publication Critical patent/NO921852L/no
Publication of NO177853B publication Critical patent/NO177853B/no
Publication of NO177853C publication Critical patent/NO177853C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Indole Compounds (AREA)
NO921852A 1989-11-22 1992-05-11 Analogifremgangsmåter for fremstilling av N-substituerte azaheterocykliske karboksylsyrer NO177853C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK588189A DK588189D0 (da) 1989-11-22 1989-11-22 Nye heterocykliske carboxylsyrer
PCT/DK1990/000302 WO1991007389A1 (en) 1989-11-22 1990-11-22 N-substituted azaheterocyclic carboxylic acids and a pharmaceutical composition

Publications (4)

Publication Number Publication Date
NO921852D0 NO921852D0 (no) 1992-05-11
NO921852L true NO921852L (no) 1992-05-11
NO177853B NO177853B (no) 1995-08-28
NO177853C NO177853C (no) 1995-12-06

Family

ID=8145900

Family Applications (1)

Application Number Title Priority Date Filing Date
NO921852A NO177853C (no) 1989-11-22 1992-05-11 Analogifremgangsmåter for fremstilling av N-substituerte azaheterocykliske karboksylsyrer

Country Status (16)

Country Link
US (1) US5198451A (no)
EP (1) EP0502031B1 (no)
JP (1) JPH05503083A (no)
AT (1) ATE157086T1 (no)
AU (1) AU660919B2 (no)
CA (1) CA2073189C (no)
DE (1) DE69031312T2 (no)
DK (2) DK588189D0 (no)
FI (1) FI97541C (no)
IE (1) IE904155A1 (no)
IL (2) IL96370A0 (no)
NO (1) NO177853C (no)
NZ (1) NZ236155A (no)
PT (1) PT95970B (no)
WO (1) WO1991007389A1 (no)
ZA (1) ZA909305B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK74693D0 (da) * 1993-06-23 1993-06-23 Novo Nordisk As Novel heterocyclic chemistry
US5962449A (en) 1995-04-07 1999-10-05 Novo Nordisk A/S Tricyclic compounds in treating hyperalgesic conditions and NIDDM
DE69738396T2 (de) * 1996-05-24 2008-12-04 Smithkline Beecham Corp. Verwendung von gaba-aufnahme-inhibitoren als mittel gegen husten
DE10204496A1 (de) * 2002-02-04 2003-08-21 Msa Auer Gmbh Vorrichtung zur Dosierung gas- und/oder dampfförmiger Stoffe

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4383999A (en) * 1981-05-26 1983-05-17 Smithkline Beckman Corporation Inhibition of GABA uptake by N-substituted azaheterocyclic carboxylic acids and their esters
DK704488D0 (da) * 1988-12-19 1988-12-19 Novo Industri As Nye n-substituerede azaheterocykliske carboxylsyrer
DK288385D0 (da) * 1985-06-26 1985-06-26 Novo Industri As Aminosyrederivater
FI864246A (fi) * 1985-11-08 1987-05-09 Warner Lambert Co N-substituerade 3-piperidin- eller 3-pyridinkarboxylsyror samt deras derivat.
US4910312A (en) * 1985-11-08 1990-03-20 Warner-Lambert Company Various N-substituted 3-piperidine carboxylic acids or N-substituted 3-pyridinecarboxylic acids and derivatives thereof
US4772615A (en) * 1985-11-08 1988-09-20 Warner-Lambert Company Various N-substituted 3-piperidine carboxylic acids or N-substituted 3-pyridinecarboxylic acids and derivatives thereof
EP0231996B1 (en) * 1986-01-07 1993-10-06 Novo Nordisk A/S Novel amino acid derivatives
US5006560A (en) * 1989-12-20 1991-04-09 Schering Corporation Use of GABA-B selective agonists as anti-tussive agents

Also Published As

Publication number Publication date
ZA909305B (en) 1991-09-25
CA2073189A1 (en) 1991-05-23
EP0502031A1 (en) 1992-09-09
DE69031312T2 (de) 1998-02-26
NO921852D0 (no) 1992-05-11
JPH05503083A (ja) 1993-05-27
IL96370A (en) 1995-01-24
ATE157086T1 (de) 1997-09-15
NO177853B (no) 1995-08-28
AU660919B2 (en) 1995-07-13
DK0502031T3 (da) 1998-03-30
FI97541B (fi) 1996-09-30
NO177853C (no) 1995-12-06
DE69031312D1 (de) 1997-09-25
AU6746490A (en) 1991-06-13
FI922268A (fi) 1992-05-19
FI922268A0 (fi) 1992-05-19
CA2073189C (en) 1998-04-07
IL96370A0 (en) 1991-08-16
PT95970B (pt) 1998-01-30
PT95970A (pt) 1991-09-13
EP0502031B1 (en) 1997-08-20
NZ236155A (en) 1993-04-28
IE904155A1 (en) 1991-05-22
US5198451A (en) 1993-03-30
DK588189D0 (da) 1989-11-22
FI97541C (fi) 1997-01-10
WO1991007389A1 (en) 1991-05-30

Similar Documents

Publication Publication Date Title
NO894014L (no) Fremgangsmaate for fremstilling av peptidase-inhibitorer.
FI962749A0 (fi) Uusia heterosyklisiä yhdisteitä
MX9707531A (es) Nuevos compuestos heterociclicos.
HUT64842A (en) Method for producing pharmaceutical preparatives containing 2-[n-(2-amino-ethyl)-amino]-acetic acid derivatives
HUT57773A (en) Process for produicng n-(aminocarbonyl)-carbamates related to physostigmine, as well as pharmaceutical compositions comprising such compounds
KR870004955A (ko) 다양한 n-치환된 3-피페리딘카복실산 또는 n-치환된 3-피리딘카복실산 및 당해 유도체
NO921852L (no) N-substituerte azaheterosykliske karboksylsyrer og en farmasoeytisk sammensetning
FI101301B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten, N-substituoitujen heksahydroatsepiinijohdannaisten valmistamiseksi
DK0599240T3 (da) Indol-7-carboxamidderivater som analgetika
DK149133C (da) Analogifremgangsmaade til fremstilling af 2-(4-(diphenylmethylen)- l-piperidinyl)- eddikesyrer eller farmaceutisk acceptable salte heraf
LV11689A (lv) 4-Ú(2-benzotiazolil)metilamino¾-alfa-Ú(3,4-difluorfenoksi)metil¾-1-piperidinetanols
PT1021404E (pt) Derivados de azetidinona para o tratamento de infeccoes pelo hcmv
ATE212637T1 (de) Anitbiotisch wirksame cephalosporine und verfahren zu ihrer herstellung
DE3863214D1 (de) Glutaminsaeurederivate, ihre salze, verfahren zu ihrer herstellung, verwendung als arzneimittel und diese enthaltende zusammensetzungen.
KR960704888A (ko) AMPA-수용체에 작용하는 알콕시-치환 β-카르보린 (Alkoxy-Substituted β-Carbolines Acting on The AMPA-Receptor)
ATE229495T1 (de) Verfahren zur herstellung von n-acyl- aminosäureestern und n-acyl-aminoacetalen